(Q45399852)

14 December 2017

title

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task (English)

1 reference

14 December 2017

1 reference

Joshua D Vardigan

1

1 reference

14 December 2017

Antonella Converso

series ordinal

2

1 reference

14 December 2017

Pete H Hutson

series ordinal

3

1 reference

14 December 2017

Jason M Uslaner

series ordinal

4

1 reference

14 December 2017

publication date

9 November 2011

1 reference

14 December 2017

published in

Journal of Neurogenetics

1 reference

14 December 2017

volume

25

1 reference

14 December 2017

issue

4

1 reference

14 December 2017

page(s)

120-126

1 reference

Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Modelling dementia: effects of scopolamine on memory and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Neuropharmacological modulation of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Inverted-U-shaped dopamine actions on human working memory and cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

cGMP: a second messenger for acetylcholine in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Nitric oxide-induced cGMP synthesis in the cholinergic system during the development and aging of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Age differences in phosphodiesterase type-IV and its functional response to dopamine D1 receptor modulation in the living brain: a PET study in conscious monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

In contrast to neuronal NOS-I, the inducible NOS-II expression in aging brains is modifled by enriched environmental conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive funct

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Attention-modulating effects of cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Hippocampal nitric oxide synthase and arginase and age-associated behavioral deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Nicotine-antipsychotic drug interactions and attentional performance in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

cGMP formation and phosphoinositide turnover in rat brain slices are mediated by pharmacologically distinct muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

Under the curve: critical issues for elucidating D1 receptor function in working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.630494

10.3109/01677063.2011.630494

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference